Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dysregulation of the Tau-Microtubule-End-Binding Protein Axis in Alzheimer's Disease and Related Tauopathies.

International journal of molecular sciences·2026
Same author

Spatio-temporal distribution patterns and risk assessment of microplastics along a coastal beach in southern Bangladesh.

Marine pollution bulletin·2026
Same author

Disrespect, Abuse, and Satisfaction With Facility-Based Childbirth in Rural Bangladesh.

Health science reports·2026
Same author

CodeStream: A dataset of iterative programming submissions with sequential verdict traces and attempt histories.

Data in brief·2026
Same author

Complete genome sequence of <i>Xanthomonas campestris</i> pv. <i>campestris</i> strain NSTU_AG-1 causing black rot disease isolated from infected cabbage leaves in Bangladesh.

Microbiology resource announcements·2026
Same author

Antibiotic practices and AMR trends in livestock farms of Mymensingh region in Bangladesh.

Journal of global antimicrobial resistance·2026
Same journal

Finite element-guided optimization of personalized vacuum bell devices for pectus excavatum: an exploratory retrospective clinical study.

Pediatric surgery international·2026
Same journal

Age and seasonality in Hirschsprung-associated enterocolitis risk: a longitudinal cohort study.

Pediatric surgery international·2026
Same journal

Neonatal single-site divided colostomy in anorectal malformation.

Pediatric surgery international·2026
Same journal

Lobectomy versus lung-sparing resection for congenital pulmonary airway malformation (CPAM): a single-center comparative study.

Pediatric surgery international·2026
Same journal

A comparative analysis of retroperitoneal small-incision open pyeloplasty and laparoscopic pyeloplasty for infantile hydronephrosis.

Pediatric surgery international·2026
Same journal

Factors associated with in-hospital mortality of neonates with anorectal malformations managed at a tertiary centre in uganda: a retrospective cohort study.

Pediatric surgery international·2026
See all related articles

Related Experiment Video

Updated: May 15, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

Propranolol for hemangiomas.

Mahmudul Hasan1, Matiur Rahman, Shafiqul Hoque

  • 1Pediatric Surgery, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh. t_mh@live.com

Pediatric Surgery International
|December 19, 2012
PubMed
Summary
This summary is machine-generated.

Oral propranolol effectively treats infantile hemangiomas, showing rapid regression within months. This study confirms propranolol

More Related Videos

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach
05:30

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach

Published on: August 8, 2025

Related Experiment Videos

Last Updated: May 15, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach
05:30

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach

Published on: August 8, 2025

Area of Science:

  • Pediatric Oncology
  • Dermatology
  • Pharmacology

Background:

  • Infantile hemangiomas are common benign tumors in children.
  • Approximately 10% of hemangiomas cause significant morbidity, requiring medical intervention.

Purpose of the Study:

  • To evaluate the efficacy and safety of propranolol for treating infantile hemangiomas.
  • To observe the adverse effects of oral propranolol in pediatric patients.

Main Methods:

  • 36 children received oral propranolol at 3 mg/kg/day, divided into three doses.
  • Blood pressure and heart rate were monitored during initial treatment.
  • Hemangioma changes were assessed using visual analog scale with pre- and post-treatment photographs.

Main Results:

  • All cases showed immediate improvement in color and growth, particularly extensive lesions.
  • Clinical regression was observed within 30 days, with complete regression in 7 months.
  • The average treatment duration was 4.1 months.

Conclusions:

  • Oral propranolol at 3 mg/kg/day demonstrates rapid stabilization and early regression of infantile hemangiomas.
  • The treatment exhibited a favorable safety profile.
  • Propranolol is an effective therapeutic option for infantile hemangiomas.